Retina-Vitreous
2022 , Vol 31 , Num 3
Anti-VEGF Treatment and Results in a Child with Juxtapapillary Choroidal Neovascular Membrane Secondary to Optic Disc Drusen
1Asst. Prof.Dr. Department of Ophthalmology, Meram School of Medicine, Necmettin Erbakan University, Konya, Türkiye2MD, Department of Ophthalmology, Meram School of Medicine, Necmettin Erbakan University, Konya, Türkiye
3Prof.Dr. Department of Ophthalmology, Meram School of Medicine, Necmettin Erbakan University, Konya, Türkiye DOI : 10.37845/ret.vit.2022.31.46 A 16-year-old patient was referred to our clinic with the complaint of blurred vision in the right eye. The best-corrected visual acuity (BCVA) was 8/10 in the right eye and 10/10 in the left eye. Fundus examination revealed bilateral slightly elevated optic disc (OD) with blurred margins. Optical coherence tomography (OCT) imaging showed subretinal fluid in the right eye at presentation and in the left eye during the follow-up. The patient was diagnosed with bilateral choroidal neovascular membrane (CNVM) secondary to optic disc drusen (ODD) and treated with intravitreal ranibizumab injections. In control visit on month 1, vision improved and the subretinal fluid was decreased in the right eye. BCVA decreased in the left eye and presented subretinal fluid at the nasal side of the macula. Therefore, bilateral ranibizumab injection was performed by 2-week interval, primarily on the left eye. After 6 month follow-up, BCVA was 10/10 in the right eye and improved to 63/100 in the left eye. Keywords : Optic disc drusen, choroidal neovascular membrane, ranibizumab, anti-VEGF